# TRANSLINK: Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves

> **NCT02023970** · NA · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 1668 (actual)

## Conditions studied

- Patients Receiving Animal-derived Bioprosthetic Heart Valves

## Interventions

- **DEVICE:** Patients receiving animal-derived bioprosthetic heart valves.
- **OTHER:** Echocardiography (1)
- **OTHER:** Echocardiography (2)
- **OTHER:** Echocardiography (3)
- **BIOLOGICAL:** Blood sample (1)
- **BIOLOGICAL:** Blood sample (2)
- **BIOLOGICAL:** Blood sample (3)

## Key facts

- **NCT ID:** NCT02023970
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-06
- **Primary completion:** 2018-01-10
- **Final completion:** 2018-01-10
- **Target enrollment:** 1668 (ACTUAL)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023970, "TRANSLINK: Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02023970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*